Can Zytiga Prevail In Pre-Chemo Prostate Cancer Without Proof Of Survival Benefit?

J&J’s abiraterone gains FDA clearance for the new claim without statistical significance for its 5-month survival advantage, but Medivation’s Xtandi is waiting in the wings – and its pre-chemo trial, PREVAIL, is likely to show a significant effect.